IHS Chemical Week

Regions :: Southeast Asia :: Singapore

Reliance Buys Biotech Firm

1:38 PM MDT | January 10, 2007 | Chemical Week Editorial Staff

Reliance Life Sciences (RLS: Mumbai), part of the Reliance Group, says it will acquire a controlling stake in biopharmaceutical company GeneMedix (Newmarket, U.K.). RLS will invest ₤32.1 million ($62.7 million) in GeneMedix over the next five years, enabling RLS to launch its biosimilars in Europe and the U.S. GeneMedix has operations in Europe, and stock exchange listings in London and Singapore. RLS’s investment will be made in two segments. An initial investment of approximately ₤14.6 million will be made for the purchase of 1.16 billion shares, or a...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week member yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine in print or digital format
  • Critical daily news and analysis on chemweek.com
  • Free mobile edition 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now

100% Satisfaction Guarantee
If at any time you are not completely satisfied with IHS Chemical Week, simply notify us and we'll refund the balance of your paid subscription - no problem.

Learn more about group subscriptions and site licenses.


contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa